T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.57B |
| 2 |
Elevance Health
ELV
|
+$1.16B |
| 3 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$1.01B |
| 4 |
Royal Caribbean
RCL
|
+$860M |
| 5 |
AET
Aetna Inc
AET
|
+$790M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$1.76B |
| 2 |
Biogen
BIIB
|
+$1.47B |
| 3 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$1.26B |
| 4 |
McKesson
MCK
|
+$1.2B |
| 5 |
Sherwin-Williams
SHW
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.75% |
| 2 | Consumer Discretionary | 14.84% |
| 3 | Financials | 13.9% |
| 4 | Technology | 11.11% |
| 5 | Industrials | 9.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TSS
1226
DELISTED
Total System Services, Inc.
TSS
| $13.5M | ﹤0.01% |
296,878
-2,100
| -0.7% | -$95.5K |
|
|
CATM
1227
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $13.3M | ﹤0.01% |
407,194
+55,600
| +16% | +$1.92M |
|
|
LDR
1228
DELISTED
Landauer Inc
LDR
| $13.3M | ﹤0.01% |
359,750
-225,920
| -39% | -$8.4M |
|
1229
Ziff Davis
ZD
$1.92B
| $13.3M | ﹤0.01% |
215,395
+17,480
| +9% | +$1.06M |
|
1230
Ralph Lauren
RL
$23.1B
| $13.2M | ﹤0.01% |
112,130
+600
| +0.5% | +$71.2K |
|
|
CLNY
1231
DELISTED
Colony Capital, Inc.
CLNY
| $13.2M | ﹤0.01% |
677,310
+4,870
| +0.7% | +$108K |
|
1232
Steel Dynamics
STLD
$37.3B
| $13.2M | ﹤0.01% |
770,078
+41,950
| +6% | +$813K |
|
1233
Woodward
WWD
$21.2B
| $13.1M | ﹤0.01% |
322,320
-677,500
| -68% | -$32M |
|
1234
Globe Life
GL
$14B
| $13.1M | ﹤0.01% |
232,226
+17,610
| +8% | +$1.05M |
|
1235
Pinnacle West Capital
PNW
$12.2B
| $13.1M | ﹤0.01% |
204,180
-100
| -0% | -$6.11K |
|
|
BID
1236
DELISTED
Sotheby's
BID
| $13M | ﹤0.01% |
407,236
+43,700
| +12% | +$1.67M |
|
|
CBM
1237
DELISTED
Cambrex Corporation
CBM
| $13M | ﹤0.01% |
327,410
+52,800
| +19% | +$2.47M |
|
|
CPHD
1238
DELISTED
Cepheid Inc
CPHD
| $13M | ﹤0.01% |
287,317
+51,261
| +22% | +$2.74M |
|
|
MORE
1239
DELISTED
Monogram Residential Trust, Inc.
MORE
| $13M | ﹤0.01% |
+1,394,440
| New | +$13.1M |
|
|
VAR
1240
DELISTED
Varian Medical Systems, Inc.
VAR
| $13M | ﹤0.01% |
200,342
-1,255
| -0.6% | -$91.6K |
|
|
XTLY
1241
DELISTED
Xactly Corporation
XTLY
| $12.9M | ﹤0.01% |
1,659,480
+259,480
| +19% | +$1.95M |
|
|
ARRS
1242
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $12.8M | ﹤0.01% |
493,814
-3,800
| -0.8% | -$108K |
|
|
SIOX
1243
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $12.8M | ﹤0.01% |
123,808
-1,192
| -1% | -$140K |
|
1244
Insteel Industries
IIIN
$634M
| $12.8M | ﹤0.01% |
793,412
-199,438
| -20% | -$3.43M |
|
1245
Blackbaud
BLKB
$2.1B
| $12.7M | ﹤0.01% |
227,000
+212,800
| +1,499% | +$12.5M |
|
1246
BioCryst Pharmaceuticals
BCRX
$2.51B
| $12.6M | ﹤0.01% |
+1,107,089
| New | +$14.8M |
|
1247
Eagle Materials
EXP
$6.41B
| $12.6M | ﹤0.01% |
184,198
-622,677
| -77% | -$48.6M |
|
|
SWNC
1248
DELISTED
Southwestern Energy Company
SWNC
| $12.6M | ﹤0.01% |
411,250
+33,200
| +9% | +$1.34M |
|
|
I
1249
DELISTED
INTELSAT S. A.
I
| $12.6M | ﹤0.01% |
1,952,470
+1,224,280
| +168% | +$11.2M |
|
1250
Diageo
DEO
$52.8B
| $12.5M | ﹤0.01% |
116,385
+9,600
| +9% | +$1.07M |
|
Similar funds
T. Rowe Price Associates's Q3 2015 Portfolio in Review
As of Q3 2015, T. Rowe Price Associates held 2,618 positions worth $449B, down 7.6% from $486B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q3 2015 filing shows 86 new, 1,108 increased, 800 reduced and 108 closed positions. Its largest new stake was BAXALTA INC COM STK (DE): 29,330,491 shares worth $924M. The largest sale was Baidu, an estimated $1.76B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q3 2015 buy was BAXALTA INC COM STK (DE): 29,330,491 shares worth $924M.
- T. Rowe Price Associates added most to Microsoft in Q3 2015, an estimated $1.57B increase.
- T. Rowe Price Associates's biggest Q3 2015 reduction was Baidu, cutting an estimated $1.76B.
- T. Rowe Price Associates fully exited HOSPIRA INC in Q3 2015, selling an estimated $988M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $449B portfolio in Q3 2015.
- T. Rowe Price Associates opened 86 new positions and closed 108 in Q3 2015.
- T. Rowe Price Associates's portfolio value fell 7.6% quarter-over-quarter to $449B.
Based on T. Rowe Price Associates's 13F filing for Q3 2015, filed 13 Nov 2015.